Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21631 AL 21645

The high frequency of periodic limb movements in patients with Lewy body dementia

Hibi S, Yamaguchi Y, Umeda-Kameyama Y, Yamamoto H, Iijima K, Momose T, Akishita M, Ouchi Y.

J Psychiatr Res. 2012 Dec;46(12):1590-4. doi: 10.1016/j.jpsychires.2012.07.007. Epub 2012 Jul 25.

Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research

Yagi T, Kosakai A, Ito D, Okada Y, Akamatsu W, Nihei Y, Nabetani A, Ishikawa F, Arai Y, Hirose N, Okano H, Suzuki N.

PLoS One. 2012;7(7):e41572. doi: 10.1371/journal.pone.0041572. Epub 2012 Jul 25.

Clinical and neuropathological findings in a patient with familial Alzheimer disease showing a mutation in the PSEN1 gene

Niwa A, Matsuo K, Shindo A, Yata K, Shiraishi T, Tomimoto H.

Neuropathology. 2013 Apr;33(2):199-203. doi: 10.1111/j.1440-1789.2012.01340.x. Epub 2012 Aug 12.

Limbic and nigral Lewy bodies and Alzheimer's disease pathology mimicking progressive supranuclear palsy in a 75-year-old man with preserved cardiac uptake of MIBG

Kasahata N, Uchihara T, Orimo S, Nakamura A, Makita Y.

J Alzheimers Dis. 2012;32(4):889-94. doi: 10.3233/JAD-2012-120445.

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, Molinuevo JL, Parnetti L, Perret-Liaudet A, Sáez-Valero J, Saka E, Urbani A, Vanmechelen E, Verbeek M, Visser PJ, Teunissen C.

Biomark Med. 2012 Aug;6(4):419-30. doi: 10.2217/bmm.12.46.

Atypical motor and behavioral presentations of Alzheimer disease: a case-based approach

Duker AP, Espay AJ, Wszolek ZK, Rademakers R, Dickson DW, Kelley BJ.

Neurologist. 2012 Sep;18(5):266-72. doi: 10.1097/NRL.0b013e3182675376.

Neuropsychological assessment of driving safety risk in older adults with and without neurologic disease

Anderson SW, Aksan N, Dawson JD, Uc EY, Johnson AM, Rizzo M.

J Clin Exp Neuropsychol. 2012;34(9):895-905. doi: 10.1080/13803395.2011.630654. Epub 2012 Sep 3.

Inflammation and neurodegeneration: the story 'retolled'

Drouin-Ouellet J, Cicchetti F.

Trends Pharmacol Sci. 2012 Oct;33(10):542-51. doi: 10.1016/j.tips.2012.07.002. Epub 2012 Aug 31.

Target-based selection of flavonoids for neurodegenerative disorders

Jones QR, Warford J, Rupasinghe HP, Robertson GS.

Trends Pharmacol Sci. 2012 Nov;33(11):602-10. doi: 10.1016/j.tips.2012.08.002. Epub 2012 Sep 12.

Pharmacological treatment of dementia

Schwarz S, Froelich L, Burns A.

Curr Opin Psychiatry. 2012 Nov;25(6):542-50. doi: 10.1097/YCO.0b013e328358e4f2.

The unravelling of metabolic dysfunctions linked to metal-associated diseases by blue native polyacrylamide gel electrophoresis

Han S, Auger C, Castonguay Z, Appanna VP, Thomas SC, Appanna VD.

Anal Bioanal Chem. 2013 Feb;405(6):1821-31. doi: 10.1007/s00216-012-6413-9. Epub 2012 Sep 22.

[Ceruloplasmin (Cp) and iron in connection with Parkinson's disease (PD) and Alzheimer's disease (AD)]

Johannesson T, Kristinsson J, Torsdottir G, Snaedal J.

Laeknabladid. 2012 Oct;98(10):531-7. doi: 10.17992/lbl.2012.10.457.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias